BlackRock’s Monogram Orthopaedics MGRM Stock Holding History

BlackRock’s Portfolio MGRM Stock Details MGRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-92,955	Closed	-$546K	–	5599
2025 Q3	$546K	Sell	92,955 -17,630	-16%	-$94.2K	﹤0.01%	4437
2025 Q2	$320K	Buy	110,585 +12,843	+13%	+$34.6K	﹤0.01%	4553
2025 Q1	$287K	Sell	97,742 -426	-0.4%	-$1.13K	﹤0.01%	4539
2024 Q4	$233K	Buy	98,168 +282	+0.3%	+$661	﹤0.01%	4592
2024 Q3	$259K	Buy	97,886 +72,922	+292%	+$190K	﹤0.01%	4472
2024 Q2	$53.7K	Buy	24,964 +20,210	+425%	+$44.3K	﹤0.01%	4845
2024 Q1	$11.6K	Sell	4,754 -728	-13%	-$2.15K	﹤0.01%	5073
2023 Q4	$18.9K	Buy	5,482 +542	+11%	+$1.63K	﹤0.01%	5089
2023 Q3	$12.8K	Buy	+4,940	New	+$20.8K	﹤0.01%	5183

BlackRock's MGRM Position: Q4 2025 in Review

BlackRock sold out of Monogram Orthopaedics (MGRM) in Q4 2025, closing a stake of 92,955 shares — an estimated $546K sold.

BlackRock first reported a position in MGRM in Q3 2023 and held it in 9 quarters. The position peaked at $546K in Q3 2025. 0 funds tracked by Wall St. Rank hold MGRM as of Q4 2025.

BlackRock reported no remaining Monogram Orthopaedics position as of Q4 2025 after selling out during the quarter.
BlackRock sold 92,955 Monogram Orthopaedics shares in Q4 2025, an estimated $546K.
BlackRock first reported a position in Monogram Orthopaedics in Q3 2023 and held it in 9 quarters.
BlackRock's Monogram Orthopaedics position peaked at $546K in Q3 2025.
0 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q4 2025.

Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.